{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T07:51:35Z","timestamp":1781596295907,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Fujian Provincial Natural Science Foundation Project","award":["2022J011490"],"award-info":[{"award-number":["2022J011490"]}]},{"name":"Fujian Medical University Qihang Fund Project","award":["2021QH1222"],"award-info":[{"award-number":["2021QH1222"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Genet Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00438-026-02471-7","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:52:20Z","timestamp":1781592740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GOLPH3 promotes papillary thyroid carcinoma by regulating the TGF-\u03b2 signaling pathway"],"prefix":"10.1007","volume":"301","author":[{"given":"Huatong","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunwen","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liumei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7783-4429","authenticated-orcid":false,"given":"Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"issue":"1","key":"2471_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/jcp.30529","volume":"237","author":"S Aashaq","year":"2022","unstructured":"Aashaq S, Batool A, Mir SA, Beigh MA, Andrabi KI, Shah ZA (2022) TGF-beta signaling: a recap of SMAD-independent and SMAD-dependent pathways. J Cell Physiol 237(1):59\u201385. https:\/\/doi.org\/10.1002\/jcp.30529","journal-title":"J Cell Physiol"},{"issue":"10387","key":"2471_CR2","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen DW, Lang BHH, McLeod DSA, Newbold K, Haymart MR (2023) Thyroid cancer. Lancet 401(10387):1531\u20131544. https:\/\/doi.org\/10.1016\/S0140-6736(23)00020-X","journal-title":"Lancet"},{"key":"2471_CR3","doi-asserted-by":"publisher","first-page":"1337883","DOI":"10.3389\/fphar.2024.1337883","volume":"15","author":"L Chen","year":"2024","unstructured":"Chen L, Chen S, Li Y, Qiu Y, Chen X, Wu Y, Deng X, Chen M, Wang C, Hong Z, Qiu C (2024) Upregulation of GOLPH3 mediated by bisphenol a promotes colorectal cancer proliferation and migration: evidence based on integrated analysis. Front Pharmacol 15:1337883. https:\/\/doi.org\/10.3389\/fphar.2024.1337883","journal-title":"Front Pharmacol"},{"issue":"6","key":"2471_CR4","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.3892\/ijo.2014.2679","volume":"45","author":"A Cohn","year":"2014","unstructured":"Cohn A, Lahn MM, Williams KE, Cleverly AL, Pitou C, Kadam SK, Farmen MW, Desaiah D, Raju R, Conkling P, Richards D (2014) A phase I dose-escalation study to a predefined dose of a transforming growth factor-beta1 monoclonal antibody (TbetaM1) in patients with metastatic cancer. Int J Oncol 45(6):2221\u20132231. https:\/\/doi.org\/10.3892\/ijo.2014.2679","journal-title":"Int J Oncol"},{"issue":"1","key":"2471_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","volume":"9","author":"Z Deng","year":"2024","unstructured":"Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C, He J (2024) TGF-beta signaling in health, disease, and therapeutics. Signal Transduct Target Ther 9(1):61. https:\/\/doi.org\/10.1038\/s41392-024-01764-w","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2471_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","volume":"18","author":"R Derynck","year":"2021","unstructured":"Derynck R, Turley SJ, Akhurst RJ (2021) TGFbeta biology in cancer progression and immunotherapy. Nat Rev Clin Oncol 18(1):9\u201334. https:\/\/doi.org\/10.1038\/s41571-020-0403-1","journal-title":"Nat Rev Clin Oncol"},{"key":"2471_CR7","doi-asserted-by":"publisher","unstructured":"Frappaolo A, Zaccagnini G, Giansanti MG (2025) GOLPH3-mTOR crosstalk and glycosylation: a molecular driver of cancer progression. Cells. https:\/\/doi.org\/10.3390\/cells14060439","DOI":"10.3390\/cells14060439"},{"issue":"11","key":"2471_CR8","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1089\/thy.2022.0317","volume":"32","author":"Q He","year":"2022","unstructured":"He Q, Cao H, Zhao Y, Chen P, Wang N, Li W, Cui R, Hou P, Zhang X, Ji M (2022) Dipeptidyl peptidase-4 stabilizes integrin alpha4beta1 complex to promote thyroid cancer cell metastasis by activating transforming growth factor-beta signaling pathway. Thyroid 32(11):1411\u20131422. https:\/\/doi.org\/10.1089\/thy.2022.0317","journal-title":"Thyroid"},{"key":"2471_CR9","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.2147\/DDDT.S86621","volume":"9","author":"S Herbertz","year":"2015","unstructured":"Herbertz S, Sawyer JS, Stauber AJ, Gueorguieva I, Driscoll KE, Estrem ST, Cleverly AL, Desaiah D, Guba SC, Benhadji KA, Slapak CA, Lahn MM (2015) Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway. Drug Des Devel Ther 9:4479\u20134499. https:\/\/doi.org\/10.2147\/DDDT.S86621","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"2471_CR10","doi-asserted-by":"publisher","first-page":"101687","DOI":"10.1016\/j.beem.2022.101687","volume":"37","author":"PV Houten","year":"2023","unstructured":"Houten PV, Netea-Maier RT, Smit JW (2023) Differentiated thyroid carcinoma: an update. Best Pract Res Clin Endocrinol Metab 37(1):101687. https:\/\/doi.org\/10.1016\/j.beem.2022.101687","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"2471_CR11","doi-asserted-by":"publisher","first-page":"188752","DOI":"10.1016\/j.bbcan.2022.188752","volume":"1877","author":"I Karnik","year":"2022","unstructured":"Karnik I, Sutherland R, Elson J, Aspinall S, Meeson A (2022) TGF-beta, to target or not to target; to prevent thyroid cancer progression? Biochim Biophys Acta Rev Cancer 1877(4):188752. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188752","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2471_CR12","doi-asserted-by":"publisher","first-page":"1265788","DOI":"10.3389\/fonc.2023.1265788","volume":"13","author":"P Kielb","year":"2023","unstructured":"Kielb P, Kaczorowski M, Kowalczyk K, Piotrowska A, Nowak L, Krajewski W, Gurwin A, Dudek K, Dziegiel P, Halon A, Szydelko T, Malkiewicz B (2023) Comparative analysis of GOLPH3 expression in lymph node-positive prostate cancer: immunohistochemistry staining patterns and clinical significance. Front Oncol 13:1265788. https:\/\/doi.org\/10.3389\/fonc.2023.1265788","journal-title":"Front Oncol"},{"issue":"1","key":"2471_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41574-019-0263-x","volume":"16","author":"J Kim","year":"2020","unstructured":"Kim J, Gosnell JE, Roman SA (2020) Geographic influences in the global rise of thyroid cancer. Nat Rev Endocrinol 16(1):17\u201329. https:\/\/doi.org\/10.1038\/s41574-019-0263-x","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2471_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13046-021-02230-z","volume":"41","author":"H Li","year":"2022","unstructured":"Li H, Zhang H, Huang G, Bing Z, Xu D, Liu J, Luo H, An X (2022) Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells. J Exp Clin Cancer Res 41(1):33. https:\/\/doi.org\/10.1186\/s13046-021-02230-z","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"2471_CR15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41419-024-07095-6","volume":"15","author":"Y Luo","year":"2024","unstructured":"Luo Y, Lu J, Lei Z, Rao D, Wang T, Fu C, Zhu H, Zhang Z, Liao Z, Liang H, Huang W (2024) GPR56 facilitates hepatocellular carcinoma metastasis by promoting the TGF-beta signaling pathway. Cell Death Dis 15(10):715. https:\/\/doi.org\/10.1038\/s41419-024-07095-6","journal-title":"Cell Death Dis"},{"issue":"6","key":"2471_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s12032-024-02355-z","volume":"41","author":"B Ma","year":"2024","unstructured":"Ma B, Xu Y, Gao H, Yang Y, Pan Y, You C (2024) CLIP170 inhibits the metastasis and EMT of papillary thyroid cancer through the TGF-beta pathway. Med Oncol 41(6):137. https:\/\/doi.org\/10.1007\/s12032-024-02355-z","journal-title":"Med Oncol"},{"issue":"10","key":"2471_CR17","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrm3434","volume":"13","author":"J Massague","year":"2012","unstructured":"Massague J (2012) TGFbeta signalling in context. Nat Rev Mol Cell Biol 13(10):616\u2013630. https:\/\/doi.org\/10.1038\/nrm3434","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2471_CR18","doi-asserted-by":"publisher","unstructured":"Ouyang J, Song F, Li H, Yang R, Huang H (2020) miR-126 targeting GOLPH3 inhibits the epithelial-mesenchymal transition of gastric cancer BGC-823 cells and reduces cell invasion. Eur J Histochem. https:\/\/doi.org\/10.4081\/ejh.2020.3168","DOI":"10.4081\/ejh.2020.3168"},{"issue":"1","key":"2471_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-022-01569-x","volume":"21","author":"D Peng","year":"2022","unstructured":"Peng D, Fu M, Wang M, Wei Y, Wei X (2022) Targeting TGF-beta signal transduction for fibrosis and cancer therapy. Mol Cancer 21(1):104. https:\/\/doi.org\/10.1186\/s12943-022-01569-x","journal-title":"Mol Cancer"},{"issue":"11","key":"2471_CR20","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/s41419-021-04265-8","volume":"12","author":"JW Song","year":"2021","unstructured":"Song JW, Zhu J, Wu XX, Tu T, Huang JQ, Chen GZ, Liang LY, Zhou CH, Xu X, Gong LY (2021) GOLPH3\/CKAP4 promotes metastasis and tumorigenicity by enhancing the secretion of exosomal WNT3A in non-small-cell lung cancer. Cell Death Dis 12(11):976. https:\/\/doi.org\/10.1038\/s41419-021-04265-8","journal-title":"Cell Death Dis"},{"key":"2471_CR21","doi-asserted-by":"publisher","first-page":"575358","DOI":"10.3389\/fonc.2020.575358","volume":"10","author":"K Wang","year":"2020","unstructured":"Wang K, Jiang S, Huang A, Gao Y, Peng B, Li Z, Ma W, Songyang Z, Zhang S, He M, Li W (2020) GOLPH3 promotes cancer growth by interacting with STIP1 and regulating telomerase activity in pancreatic ductal adenocarcinoma. Front Oncol 10:575358. https:\/\/doi.org\/10.3389\/fonc.2020.575358","journal-title":"Front Oncol"},{"key":"2471_CR22","doi-asserted-by":"publisher","first-page":"116888","DOI":"10.1016\/j.bcp.2025.116888","volume":"236","author":"Y Wu","year":"2025","unstructured":"Wu Y, Lin B, Xie Z, Huang J, Qiu Y, Chen X, Hong Z, Qiu C (2025) SUMOylation of RAD51 upregulates GOLPH3 expression and promotes cisplatin resistance in colon cancer cells by Sp1 transcriptional activity. Biochem Pharmacol 236:116888. https:\/\/doi.org\/10.1016\/j.bcp.2025.116888","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"2471_CR23","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.7150\/ijbs.89568","volume":"20","author":"X Xin","year":"2024","unstructured":"Xin X, Cheng X, Zeng F, Xu Q, Hou L (2024) The role of TGF-beta\/SMAD signaling in hepatocellular carcinoma: from mechanism to therapy and prognosis. Int J Biol Sci 20(4):1436\u20131451. https:\/\/doi.org\/10.7150\/ijbs.89568","journal-title":"Int J Biol Sci"},{"key":"2471_CR24","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.3389\/fonc.2019.01424","volume":"9","author":"LN Yu","year":"2019","unstructured":"Yu LN, Liu Z, Tian Y, Zhao PP, Hua X (2019) FAP-a and GOLPH3 are hallmarks of DCIS progression to invasive breast cancer. Front Oncol 9:1424. https:\/\/doi.org\/10.3389\/fonc.2019.01424","journal-title":"Front Oncol"},{"issue":"5","key":"2471_CR25","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/PAI.0000000000001117","volume":"31","author":"WS Yu","year":"2023","unstructured":"Yu WS, Zhou ZP, Zeng JF, Huang ZQ, Qiu CZ (2023) Expression and clinical significance of Golgi phosphoprotein 3 (GOLPH3) in papillary thyroid carcinoma. Appl Immunohistochem Mol Morphol 31(5):324\u2013330. https:\/\/doi.org\/10.1097\/PAI.0000000000001117","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2471_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2024.04.001","volume":"101","author":"YE Zhang","year":"2024","unstructured":"Zhang YE, Stuelten CH (2024) Alternative splicing in EMT and TGF-beta signaling during cancer progression. Semin Cancer Biol 101:1\u201311. https:\/\/doi.org\/10.1016\/j.semcancer.2024.04.001","journal-title":"Semin Cancer Biol"},{"key":"2471_CR27","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.2147\/OTT.S249994","volume":"13","author":"C Zhao","year":"2020","unstructured":"Zhao C, Zhang J, Ma L, Wu H, Zhang H, Su J, Geng B, Yao Q, Zheng J (2020) GOLPH3 promotes angiogenesis of lung adenocarcinoma by regulating the Wnt\/beta-catenin signaling pathway. Onco Targets Ther 13:6265\u20136277. https:\/\/doi.org\/10.2147\/OTT.S249994","journal-title":"Onco Targets Ther"},{"key":"2471_CR28","doi-asserted-by":"publisher","first-page":"1438235","DOI":"10.3389\/fimmu.2024.1438235","volume":"15","author":"X Zheng","year":"2024","unstructured":"Zheng X, Sun R, Wei T (2024) Immune microenvironment in papillary thyroid carcinoma: roles of immune cells and checkpoints in disease progression and therapeutic implications. Front Immunol 15:1438235. https:\/\/doi.org\/10.3389\/fimmu.2024.1438235","journal-title":"Front Immunol"},{"issue":"2","key":"2471_CR29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.21037\/jgo-2025-193","volume":"16","author":"K Zhu","year":"2025","unstructured":"Zhu K, Fan J, Cai H, Zhou C, Gong Z, Li Z, Yu J (2025) The highly expressed GOLPH3 in colorectal cancer cells activates smoothened to drive glycolysis and promote cancer cell growth and radiotherapy resistance. J Gastrointest Oncol 16(2):415\u2013434. https:\/\/doi.org\/10.21037\/jgo-2025-193","journal-title":"J Gastrointest Oncol"}],"container-title":["Molecular Genetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-026-02471-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00438-026-02471-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-026-02471-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:52:21Z","timestamp":1781592741000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00438-026-02471-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2471"],"URL":"https:\/\/doi.org\/10.1007\/s00438-026-02471-7","relation":{},"ISSN":["1617-4615","1617-4623"],"issn-type":[{"value":"1617-4615","type":"print"},{"value":"1617-4623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"139"}}